research use only
Cat.No.S3155
| Related Targets | CFTR CRM1 CD markers AChR Calcium Channel Potassium Channel GABA Receptor TRP Channel ATPase GluR |
|---|---|
| Other Sodium Channel Inhibitors | Camostat Mesilate A-803467 cariporide Tolperisone HCl Vinpocetine Veratramine Bulleyaconi cine A Ambroxol HCl Benzocaine Nefopam HCl |
| Molecular Weight | 282.81 | Formula | C15H22N2O.HCl |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1722-62-9 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl | ||
|
In vitro |
Water : 57 mg/mL Ethanol : 8 mg/mL
DMSO
: 3 mg/mL
(10.6 mM)
|
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| In vivo |
The tests made in horse show greater diffusion of Mepivacaine between adjacent synovial structures than assumed from previous anatomical, latex injection and contrast arthrographic studies. Ultrasound provides a 37% reduction in the minimum effective anesthetic volume (MEAV50) of 1.5% Mepivacaine required to block the sciatic nerve compared with neurostimulation in patients undergoing knee arthroscopy. The use of 3% Mepivacaine provides a shorter duration of anesthesia than the lidocaine formulations with epinephrine in the canines and premolars.
|
References |
|
|---|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT04257682 | Not yet recruiting | Knee Osteoarthritis|Hip Osteoarthritis |
Ottawa Hospital Research Institute |
September 2022 | Phase 4 |
| NCT01533545 | Terminated | Renal Insufficiency Chronic |
Rigshospitalet Denmark |
September 2012 | Not Applicable |
| NCT01032798 | Completed | Local Anesthetic Effectiveness |
University of Campinas Brazil|Fundação de Amparo à Pesquisa do Estado de São Paulo |
May 2007 | Phase 1 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.